Fang‐Tsyr Lin

7.5k total citations · 4 hit papers
46 papers, 6.3k citations indexed

About

Fang‐Tsyr Lin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Fang‐Tsyr Lin has authored 46 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Cell Biology. Recurrent topics in Fang‐Tsyr Lin's work include Receptor Mechanisms and Signaling (13 papers), DNA Repair Mechanisms (11 papers) and Cancer-related Molecular Pathways (11 papers). Fang‐Tsyr Lin is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), DNA Repair Mechanisms (11 papers) and Cancer-related Molecular Pathways (11 papers). Fang‐Tsyr Lin collaborates with scholars based in United States, Taiwan and Canada. Fang‐Tsyr Lin's co-authors include Robert J. Lefkowitz, Marc G. Caron, Raul R. Gainetdinov, Laura Bohn, William E. Miller, Yehia Daaka, Weei-Chin Lin, Karsten Peppel, Stephen S. G. Ferguson and Louis M. Luttrell and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Fang‐Tsyr Lin

46 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

β-Arrestin-Dependent Formation of β ₂ Adrenergic Receptor-Src Protein Kinase Complexes

1999 1.2k citations Yehia Daaka, William E. Miller et al. Science profile →
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2

1999 830 citations Laura Bohn, Robert J. Lefkowitz et al. Science profile →
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence

2000 753 citations Laura Bohn, Raul R. Gainetdinov et al. Nature profile →
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3

2000 699 citations Patricia McDonald, William E. Miller et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fang‐Tsyr Lin United States	33	5.4k	3.0k	855	669	646	46	6.3k
Kristen L. Pierce United States	25	5.1k 0.9×	2.5k 0.8×	634 0.7×	537 0.8×	548 0.8×	36	6.5k
Brian E. Hawes United States	35	4.1k 0.8×	1.6k 0.6×	498 0.6×	583 0.9×	567 0.9×	71	5.7k
Kathryn DeFea United States	31	3.2k 0.6×	1.3k 0.4×	412 0.5×	585 0.9×	476 0.7×	52	4.8k
Julie A. Pitcher United States	33	5.8k 1.1×	2.8k 0.9×	376 0.4×	545 0.8×	1.0k 1.6×	37	6.7k
Éric Reiter France	38	4.2k 0.8×	2.2k 0.7×	378 0.4×	273 0.4×	268 0.4×	103	5.8k
Erin J. Whalen United States	29	4.0k 0.7×	2.1k 0.7×	367 0.4×	796 1.2×	228 0.4×	48	5.2k
Seungkirl Ahn United States	43	8.6k 1.6×	4.7k 1.6×	1.1k 1.3×	691 1.0×	788 1.2×	52	10.1k
Arun K. Shukla India	37	5.3k 1.0×	3.1k 1.0×	366 0.4×	294 0.4×	349 0.5×	101	6.1k
Neil J. Freedman United States	35	4.0k 0.7×	1.8k 0.6×	374 0.4×	506 0.8×	357 0.6×	58	5.4k
Trudy A. Kohout United States	27	3.1k 0.6×	1.6k 0.5×	420 0.5×	295 0.4×	352 0.5×	34	3.8k

Countries citing papers authored by Fang‐Tsyr Lin

Since Specialization

Citations

This map shows the geographic impact of Fang‐Tsyr Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang‐Tsyr Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang‐Tsyr Lin more than expected).

Fields of papers citing papers by Fang‐Tsyr Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang‐Tsyr Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang‐Tsyr Lin. The network helps show where Fang‐Tsyr Lin may publish in the future.

Co-authorship network of co-authors of Fang‐Tsyr Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Fang‐Tsyr Lin. A scholar is included among the top collaborators of Fang‐Tsyr Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang‐Tsyr Lin. Fang‐Tsyr Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Kang, et al.. (2025). Mutant p53 variants differentially impact replication initiation and activate cGAS-STING to affect immune checkpoint inhibition. Communications Biology. 8(1). 1522–1522. 1 indexed citations

Lin, Fang‐Tsyr, et al.. (2023). DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors. Cancer Research Communications. 3(10). 2096–2112. 5 indexed citations

Ho, Shiuh‐Rong, Yu‐Cheng Lee, Michael Ittmann, et al.. (2021). RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis. Cancer Letters. 520. 344–360. 23 indexed citations

Liu, Kang, et al.. (2021). Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer. Journal of Biological Chemistry. 296(1). 100382–100382. 8 indexed citations

Xiao, Yang, Fang‐Tsyr Lin, & Weei-Chin Lin. (2021). ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer. Proceedings of the National Academy of Sciences. 118(3). 58 indexed citations

Liu, Kang, et al.. (2017). Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin. Proceedings of the National Academy of Sciences. 114(19). 32 indexed citations

Lin, Fang‐Tsyr, et al.. (2016). TRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation. Cell Discovery. 2(1). 17 indexed citations

Fells, James I., Sue-Chin Lee, Jianxiong Liu, et al.. (2012). Virtual Screening for LPA2-Specific Agonists Identifies a Nonlipid Compound with Antiapoptotic Actions. Molecular Pharmacology. 82(6). 1162–1173. 52 indexed citations

Shuyu, E, Yun‐Ju Lai, Ryoko Tsukahara, et al.. (2009). Lysophosphatidic Acid 2 Receptor-mediated Supramolecular Complex Formation Regulates Its Antiapoptotic Effect. Journal of Biological Chemistry. 284(21). 14558–14571. 59 indexed citations

10.

Lin, Fang‐Tsyr, Yun‐Ju Lai, Natalia Makarova, Gábor Tigyi, & Weei-Chin Lin. (2007). The Lysophosphatidic Acid 2 Receptor Mediates Down-regulation of Siva-1 to Promote Cell Survival. Journal of Biological Chemistry. 282(52). 37759–37769. 58 indexed citations

11.

Lai, Yun‐Ju, Weei-Chin Lin, & Fang‐Tsyr Lin. (2007). PTPL1/FAP-1 Negatively Regulates TRIP6 Function in Lysophosphatidic Acid-induced Cell Migration. Journal of Biological Chemistry. 282(33). 24381–24387. 28 indexed citations

12.

Liu, Kang, Jason C. Paik, Bing Wang, Fang‐Tsyr Lin, & Weei-Chin Lin. (2006). Regulation of TopBP1 oligomerization by Akt/PKB for cell survival. The EMBO Journal. 25(20). 4795–4807. 81 indexed citations

13.

Liu, Kang, et al.. (2004). TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival. Genes & Development. 18(6). 673–686. 127 indexed citations

14.

Lin, Fang‐Tsyr, et al.. (2004). ATM-Mediated Stabilization of hMutL DNA Mismatch Repair Proteins Augments p53 Activation during DNA Damage. Molecular and Cellular Biology. 24(14). 6430–6444. 58 indexed citations

15.

Wu, Jiao‐Hui, Karsten Peppel, Christopher Nelson, et al.. (2003). The Adaptor Protein β-Arrestin2 Enhances Endocytosis of the Low Density Lipoprotein Receptor. Journal of Biological Chemistry. 278(45). 44238–44245. 44 indexed citations

16.

Cong, Mei, Stephen J. Perry, Fang‐Tsyr Lin, et al.. (2001). Regulation of Membrane Targeting of the G Protein-coupled Receptor Kinase 2 by Protein Kinase A and Its Anchoring Protein AKAP79. Journal of Biological Chemistry. 276(18). 15192–15199. 139 indexed citations

17.

Bohn, Laura, Raul R. Gainetdinov, Fang‐Tsyr Lin, Robert J. Lefkowitz, & Marc G. Caron. (2000). μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature. 408(6813). 720–723. 753 indexed citations breakdown →

18.

McDonald, Patricia, et al.. (1999). Identification of NSF as a β-Arrestin1-binding Protein. Journal of Biological Chemistry. 274(16). 10677–10680. 121 indexed citations

19.

Bohn, Laura, Robert J. Lefkowitz, Raul R. Gainetdinov, et al.. (1999). Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2. Science. 286(5449). 2495–2498. 830 indexed citations breakdown →

20.

Lin, Fang‐Tsyr, Yehia Daaka, & Robert J. Lefkowitz. (1998). β-Arrestins Regulate Mitogenic Signaling and Clathrin-mediated Endocytosis of the Insulin-like Growth Factor I Receptor. Journal of Biological Chemistry. 273(48). 31640–31643. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact